Aram Demirjian
Assistant Professor, Surgery
School of Medicine
School of Medicine
M.D., Boston University, 2002
University of California, Irvine
333 City Blvd West, Suite 1205
Orange, CA 92868
333 City Blvd West, Suite 1205
Orange, CA 92868
Research Interests
Pancreatitis, Bile Duct Cancer, Colorectal Liver Metastases, Gallbladder Cancer, Hepatocellular Carcinoma, IPMN, Islet Cell Transplantation, Pancreatic Neuroendocrine Tumors, Pancreatic Adenocarcinoma
Publications
Book Chapters
1. Demirjian AN, Ahuja N. Las complicaciones de la exploración retroperitoneal. In: Complicaciones en Cirugía General, ed. Espinoza RG. August 2011.
2. Demirjian AN, Mullen JT. Skin and Soft Tissue. In: Pocket Surgery, ed. Goldfarb M, Gromski MA, Hurst JM, and Jones DB. October 2011.
3. Demirjian AN, Schulick RD. Diagnostic Operations of the Liver and Techniques of Hepatic Resection. In: Shackleford’s Surgery of the Alimentary Tract, ed. Yeo C, Matthews J, McFadden D, Pemberton J, and Peters J. August 2012.
4. Cunningham SC, Demirjian AN, Schulick RD. Pancreaticobiliary Surgery. In: Master Techniques in Hepatobiliary and Pancreatic Surgery, ed. Lillemoe K and Jarnagin W. October 2012.
5. Demirjian AN, Cunningham SC, Pawlik TM. Hilar Cholangiocarcinoma. In: Hepatobiliary Cancer, ed. Fong Y, Poon R, Tang ZY, Dupuy D, and Berlin JD. December 2013.
1. Demirjian AN, Ahuja N. Las complicaciones de la exploración retroperitoneal. In: Complicaciones en Cirugía General, ed. Espinoza RG. August 2011.
2. Demirjian AN, Mullen JT. Skin and Soft Tissue. In: Pocket Surgery, ed. Goldfarb M, Gromski MA, Hurst JM, and Jones DB. October 2011.
3. Demirjian AN, Schulick RD. Diagnostic Operations of the Liver and Techniques of Hepatic Resection. In: Shackleford’s Surgery of the Alimentary Tract, ed. Yeo C, Matthews J, McFadden D, Pemberton J, and Peters J. August 2012.
4. Cunningham SC, Demirjian AN, Schulick RD. Pancreaticobiliary Surgery. In: Master Techniques in Hepatobiliary and Pancreatic Surgery, ed. Lillemoe K and Jarnagin W. October 2012.
5. Demirjian AN, Cunningham SC, Pawlik TM. Hilar Cholangiocarcinoma. In: Hepatobiliary Cancer, ed. Fong Y, Poon R, Tang ZY, Dupuy D, and Berlin JD. December 2013.
Abstracts
1. Bai J, Demirjian AN, Vollmer CM, Callery MP. Bcl-XL depletion sensitizes pancreatic cancer cells to ligand-mediated apoptosis. Journal of Gastrointestinal Surgery. 2005;9(4):529.
2. Bai J, Demirjian AN, Vollmer CM, Callery, MP. Developing novel biological therapies that drive apoptosis and overcome chemoresistance in pancreatic cancer cells. Journal of Gastrointestinal Surgery. 2005;9(4):611-612.
3. Demirjian AN, Bai J, Callery MP. Bcl-XL Depletion Promotes Apoptosis and Retards Growth of Pancreatic Cancer Tumor Xenografts. Journal of Surgical Research. 2006;130(2):163-164.
4. Demirjian AN, Bai J, Callery MP. Limiting pancreatic cancer growth via control of Bcl-XL-dependent factors. HPB. 2006;8(Supplement Number 1):36.
5. Demirjian AN, McDermott DF, Vollmer CM, Atkins MB, Callery MP. Refined indications for palliative resection of metastatic renal cell carcinoma to the pancreas. HPB. 2006;8(Supplement Number 1):57.
6. Demirjian A, Kent T, Callery M, Vollmer C. The Unpredictable Nature of Pancreaticojejunostomy Anastomotic Strictures. (Presented - 9th World Congress of the International Hepato-Pancreato-Biliary Association, 18-22 April 2010, Buenos Aires, Argentina).
7. Demirjian A, Findeiss L, Lall C, Imagawa D. Use of CT angiography to diagnose associated vascular injuries in patients with common bile duct injuries following cholecystectomy. HPB. 2012;14(Supplement Number 2):117.
8. Lall C, Bhargava P, Helmy M, Verma S, Findeiss LK, Demirjian A, Roumanis P, Imagawa D. Duplex Doppler findings in cirrhosis and portal hypertension: Beyond flow reversal! (American Roentgen Ray Society Annual Meeting).
9. Lafaro KJ, Tran G, Fernando D, Vajgrt DJ, Findeiss LK, Demirjian AN, Imagawa DK. Operative management of necrotizing pancreatitis at a single institution. (Presented – Americas Hepato-Pancreato-Biliary Association annual meeting, February 2013).
10. Chen J, Findeiss L, Demirjian AN, Imagawa DK. Evolution of the Treatment of Gastroduodenal Artery Pseudoaneurysms and Mesenteric Arterial Hemorrhage Following Pancreaticoduodenectomy. (SSAT Abstract Presented at DDW 2013).
11. Kim J, Demirjian AN, Imagawa DK. Surgical Management of Pancreatic Neuroendocrine Tumors: A Single Institution Experience. (SSAT Abstract Presented at DDW 2013).
12. Khalsa BS, Imagawa DK, Chen JI, Demirjian AN, Yim DB, Findeiss LK. Evolution in the treatment of delayed postpancreatectomy hemorrhage: A trend towards Interventional Radiology. (SIR 39th Annual Scientific Meeting, San Diego, CA 2014).
13. Sgroi MD, Narayan RS, Lane JS, Demirjian AN, Fujitani RM, Imagawa DK. Vascular Reconstruction Plays an Important Role in the Treatment of Pancreatic Adenocarcinoma. (SVS Annual Meeting, Boston, MA 2014).
14. Muscianese L, Feldmann T, Demirjian A, Imagawa D. Overall Risk of Pancreatic Adenocarcinoma in Autoimmune Pancreatitis: Role of Early Screening Recommendations. (American College of Surgeons Southern California Chapter Annual Meeting, Santa Barbara, CA 2015).
15. Daar DA, Demirjian AN, Imagawa DK. Inaccuracies in the ACS-NSQIP Database for Hepatic Surgery: Failure to Detect Liver-Specific Complications. (Pacific Coast Surgical Association Annual Meeting, Monterey, CA 2015).
16. Storino A, Castillo-Angeles M, Watkins AA, Vargas C, Klompmaker S, Mancias J, Bullock A, Demirjian A, Moser AJ, Kent TS. Readability and Accuracy of Online Patient Materials for Pancreatic Cancer by Treatment Modality and Website Affiliation. (Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami Beach, FL 2015).
17. Hwang GS, Moghadamyeghaneh Z, Hanna MH, Phelan MJ, Stamos MJ, Imagawa DK, Demirjian A. MELD as a predictor of mortality after cholecystectomy. JACS. 2015;221(4):e99-e100.
18. Hanna MH, Moghadamyeghaneh Z, Alizadeh RF, Nguyen A, Yamamoto M, Stamos MJ, Demirjian AN, Imagawa DK. Readmission after Pancreaticoduodenectomy: An Analysis of Risk Factors and Timing of Complications. JACS. 2015;221(4):S93-S94.
19. Hanna MH, Moghadamyeghaneh Z, Hwang GS, Alizadeh RF, Nguyen A, Yamamoto M, Stamos MJ, Imagawa DK, Demirjian AN. Contemporary pancreatic necrosectomy: an analysis of outcomes, mortality and timing of intervention. JACS. 2015;221(4):e93.
1. Bai J, Demirjian AN, Vollmer CM, Callery MP. Bcl-XL depletion sensitizes pancreatic cancer cells to ligand-mediated apoptosis. Journal of Gastrointestinal Surgery. 2005;9(4):529.
2. Bai J, Demirjian AN, Vollmer CM, Callery, MP. Developing novel biological therapies that drive apoptosis and overcome chemoresistance in pancreatic cancer cells. Journal of Gastrointestinal Surgery. 2005;9(4):611-612.
3. Demirjian AN, Bai J, Callery MP. Bcl-XL Depletion Promotes Apoptosis and Retards Growth of Pancreatic Cancer Tumor Xenografts. Journal of Surgical Research. 2006;130(2):163-164.
4. Demirjian AN, Bai J, Callery MP. Limiting pancreatic cancer growth via control of Bcl-XL-dependent factors. HPB. 2006;8(Supplement Number 1):36.
5. Demirjian AN, McDermott DF, Vollmer CM, Atkins MB, Callery MP. Refined indications for palliative resection of metastatic renal cell carcinoma to the pancreas. HPB. 2006;8(Supplement Number 1):57.
6. Demirjian A, Kent T, Callery M, Vollmer C. The Unpredictable Nature of Pancreaticojejunostomy Anastomotic Strictures. (Presented - 9th World Congress of the International Hepato-Pancreato-Biliary Association, 18-22 April 2010, Buenos Aires, Argentina).
7. Demirjian A, Findeiss L, Lall C, Imagawa D. Use of CT angiography to diagnose associated vascular injuries in patients with common bile duct injuries following cholecystectomy. HPB. 2012;14(Supplement Number 2):117.
8. Lall C, Bhargava P, Helmy M, Verma S, Findeiss LK, Demirjian A, Roumanis P, Imagawa D. Duplex Doppler findings in cirrhosis and portal hypertension: Beyond flow reversal! (American Roentgen Ray Society Annual Meeting).
9. Lafaro KJ, Tran G, Fernando D, Vajgrt DJ, Findeiss LK, Demirjian AN, Imagawa DK. Operative management of necrotizing pancreatitis at a single institution. (Presented – Americas Hepato-Pancreato-Biliary Association annual meeting, February 2013).
10. Chen J, Findeiss L, Demirjian AN, Imagawa DK. Evolution of the Treatment of Gastroduodenal Artery Pseudoaneurysms and Mesenteric Arterial Hemorrhage Following Pancreaticoduodenectomy. (SSAT Abstract Presented at DDW 2013).
11. Kim J, Demirjian AN, Imagawa DK. Surgical Management of Pancreatic Neuroendocrine Tumors: A Single Institution Experience. (SSAT Abstract Presented at DDW 2013).
12. Khalsa BS, Imagawa DK, Chen JI, Demirjian AN, Yim DB, Findeiss LK. Evolution in the treatment of delayed postpancreatectomy hemorrhage: A trend towards Interventional Radiology. (SIR 39th Annual Scientific Meeting, San Diego, CA 2014).
13. Sgroi MD, Narayan RS, Lane JS, Demirjian AN, Fujitani RM, Imagawa DK. Vascular Reconstruction Plays an Important Role in the Treatment of Pancreatic Adenocarcinoma. (SVS Annual Meeting, Boston, MA 2014).
14. Muscianese L, Feldmann T, Demirjian A, Imagawa D. Overall Risk of Pancreatic Adenocarcinoma in Autoimmune Pancreatitis: Role of Early Screening Recommendations. (American College of Surgeons Southern California Chapter Annual Meeting, Santa Barbara, CA 2015).
15. Daar DA, Demirjian AN, Imagawa DK. Inaccuracies in the ACS-NSQIP Database for Hepatic Surgery: Failure to Detect Liver-Specific Complications. (Pacific Coast Surgical Association Annual Meeting, Monterey, CA 2015).
16. Storino A, Castillo-Angeles M, Watkins AA, Vargas C, Klompmaker S, Mancias J, Bullock A, Demirjian A, Moser AJ, Kent TS. Readability and Accuracy of Online Patient Materials for Pancreatic Cancer by Treatment Modality and Website Affiliation. (Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami Beach, FL 2015).
17. Hwang GS, Moghadamyeghaneh Z, Hanna MH, Phelan MJ, Stamos MJ, Imagawa DK, Demirjian A. MELD as a predictor of mortality after cholecystectomy. JACS. 2015;221(4):e99-e100.
18. Hanna MH, Moghadamyeghaneh Z, Alizadeh RF, Nguyen A, Yamamoto M, Stamos MJ, Demirjian AN, Imagawa DK. Readmission after Pancreaticoduodenectomy: An Analysis of Risk Factors and Timing of Complications. JACS. 2015;221(4):S93-S94.
19. Hanna MH, Moghadamyeghaneh Z, Hwang GS, Alizadeh RF, Nguyen A, Yamamoto M, Stamos MJ, Imagawa DK, Demirjian AN. Contemporary pancreatic necrosectomy: an analysis of outcomes, mortality and timing of intervention. JACS. 2015;221(4):e93.
Invited Reviews, Editorials
1. Demirjian AN, Callery MP. Environment, genetics, and fish? Answers to the cancer riddle. Gastroenterology. 2006;130(3):1000-1
2. Demirjian AN, Efron JE. Multimodality Treatment and Timing for Rectal Cancer in Hereditary Colorectal Cancer Patients. Semin Colon Rectal Surg. 2011;22(2):137-140.
3. Haddad A, Cunningham SC, Demirjian A. Letter to the Editor: "Impact of age over 75 years on outcomes after pancreaticoduodenectomy". J Surg Res. 2013;187(2):718-9.
4. Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK. Gd-EOB-DTPA enhanced MRI for detection of liver metastases from colorectal cancer: A surgeon’s perspective. Int J Hepatol. 2013;2013:572307, Epub 2013 Apr 9.
5. Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of Hepatocellular Carcinoma. Surg Oncol Clin N Am. 2015;24(1):1-17.
1. Demirjian AN, Callery MP. Environment, genetics, and fish? Answers to the cancer riddle. Gastroenterology. 2006;130(3):1000-1
2. Demirjian AN, Efron JE. Multimodality Treatment and Timing for Rectal Cancer in Hereditary Colorectal Cancer Patients. Semin Colon Rectal Surg. 2011;22(2):137-140.
3. Haddad A, Cunningham SC, Demirjian A. Letter to the Editor: "Impact of age over 75 years on outcomes after pancreaticoduodenectomy". J Surg Res. 2013;187(2):718-9.
4. Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK. Gd-EOB-DTPA enhanced MRI for detection of liver metastases from colorectal cancer: A surgeon’s perspective. Int J Hepatol. 2013;2013:572307, Epub 2013 Apr 9.
5. Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of Hepatocellular Carcinoma. Surg Oncol Clin N Am. 2015;24(1):1-17.
Publications: Peer Reviewed
1. Short MK, Jeffrey PD, Demirjian A, Margolies MN. A single H:CDR3 residue in the anti-digoxin antibody 26-10 modulates specificity for C16-substituted digoxin analogs. Protein Eng. 2001;14(4):287-296.
2. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Predominant Bcl-XL Knockdown Disables Antiapoptotic Mechanisms: Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Based Triple Chemotherapy Overcomes Chemoresistance in Pancreatic Cancer Cells In vitro. Cancer Res. 2005;65(6):2344-52.
3. Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun. 2006;348(4):1245-53.
4. Demirjian AN, Grossman JM, Chan JL, Parangi S. Parathyroid carcinoma and neurofibromatosis. Surgery. 2008;144(5):827-829.
5. Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP. Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB. 2009;11(2):150-153.
6. Demirjian AN, Kent TS, Callery MP, Vollmer CM. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB. 2010;12(7):482-7.
7. Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM. Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest. J Gastrointest Surg. 2011;15(11):2089-97.
8. Vollmer CM, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD, Callery MP, The Pancreatic Surgery Mortality Study Group. A Root-Cause Analysis of Mortality Following Major Pancreatectomy. J Gastrointest Surg. 2012;16:89-103.
9. Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, Cameron A, Gurakar A, Cosgrove D, Choti MA, Geschwind JF, Kamel IR, Pawlik TM. Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes. Ann Surg Oncol. 2012;19(9):2897-907.
10. Koh C, Demirjian AN, Chen WP, McLaren CE, Imagawa DK. Validation of Revised American Joint Committee on Cancer Staging for Gallbladder Cancer Based on a Single Institution Experience. Am Surg. 2013;79(10):1045-1049.
11. Halabi WJ, Kang CY, Ketana N, Lafaro KJ, Nguyen VQ, Stamos MJ, Imagawa DK, Demirjian AN. Surgery for Gallstone Ileus: A Nationwide Comparison of Trends and Outcomes. Ann Surg. 2014;259(2):329-335.
12. Bruns SD, Davis BR, Demirjian AN, Ganai S, House MG, Saidi RF, Shah BC, Tan SA, Murayama KM. The Subspecialization of Surgery: A Paradigm Shift. J Gastrointest Surg. 2014;18(8):1523-31.
13. Nayyar M, Imagawa DK, Tirkes T, Demirjian AN, Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C. Composite liver tumors: a radiologic-pathologic correlation. Clin Mol Hepatol. 2014;20(4):406-10.
14. Sgroi MD, Narayan RR, Lane JS, Demirjian A, Kabutey NK, Fujitani RM, Imagawa DK. Vascular Reconstruction plays an Important Role in the Treatment of Pancreatic Adenocarcinoma. J Vasc Surg. 2015;61(2):475-80.
15. Roumanis PS, Aubin GK, Choi JI, Bhargava P, Demirjian AN, Thayer DA, Lall C. Atypical magnetic resonance imaging findings in hepatocellular carcinoma. Curr Probl Diagn Radiol. 2015;44(3):237-245.
16. Rinehart J, Lilot M, Lee C, Joosten A, Huynh T, Canales C, Imagawa D, Demirjian A, Cannesson M. Closed-loop assisted versus manual goal-directed fluid therapy during high-risk abdominal surgery: a case-control study with propensity matching. Crit Care. 2015;19(1):94.
17. Khalsa B, Imagawa DK, Chen JI, Demirjian AN, Yim DB, Findeiss LK. Evolution in the treatment of delayed postpancreatectomy hemorrhage: Surgery to Interventional Radiology. Pancreas. 2015;44(6):953-8.
18. Cannesson M, Ramsingh D, Rinehart J, Demirjian A, Vu T, Vakharia S, Imagawa D, Yu Z, Greenfield S, Kain Z. Perioperative goal directed therapy and postoperative outcomes in patients undergoing high-risk abdominal surgery: a historical-prospective, comparative effectiveness study. Crit Care. 2015;19(1):261.
1. Short MK, Jeffrey PD, Demirjian A, Margolies MN. A single H:CDR3 residue in the anti-digoxin antibody 26-10 modulates specificity for C16-substituted digoxin analogs. Protein Eng. 2001;14(4):287-296.
2. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Predominant Bcl-XL Knockdown Disables Antiapoptotic Mechanisms: Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Based Triple Chemotherapy Overcomes Chemoresistance in Pancreatic Cancer Cells In vitro. Cancer Res. 2005;65(6):2344-52.
3. Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun. 2006;348(4):1245-53.
4. Demirjian AN, Grossman JM, Chan JL, Parangi S. Parathyroid carcinoma and neurofibromatosis. Surgery. 2008;144(5):827-829.
5. Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP. Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB. 2009;11(2):150-153.
6. Demirjian AN, Kent TS, Callery MP, Vollmer CM. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB. 2010;12(7):482-7.
7. Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM. Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest. J Gastrointest Surg. 2011;15(11):2089-97.
8. Vollmer CM, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD, Callery MP, The Pancreatic Surgery Mortality Study Group. A Root-Cause Analysis of Mortality Following Major Pancreatectomy. J Gastrointest Surg. 2012;16:89-103.
9. Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, Cameron A, Gurakar A, Cosgrove D, Choti MA, Geschwind JF, Kamel IR, Pawlik TM. Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes. Ann Surg Oncol. 2012;19(9):2897-907.
10. Koh C, Demirjian AN, Chen WP, McLaren CE, Imagawa DK. Validation of Revised American Joint Committee on Cancer Staging for Gallbladder Cancer Based on a Single Institution Experience. Am Surg. 2013;79(10):1045-1049.
11. Halabi WJ, Kang CY, Ketana N, Lafaro KJ, Nguyen VQ, Stamos MJ, Imagawa DK, Demirjian AN. Surgery for Gallstone Ileus: A Nationwide Comparison of Trends and Outcomes. Ann Surg. 2014;259(2):329-335.
12. Bruns SD, Davis BR, Demirjian AN, Ganai S, House MG, Saidi RF, Shah BC, Tan SA, Murayama KM. The Subspecialization of Surgery: A Paradigm Shift. J Gastrointest Surg. 2014;18(8):1523-31.
13. Nayyar M, Imagawa DK, Tirkes T, Demirjian AN, Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C. Composite liver tumors: a radiologic-pathologic correlation. Clin Mol Hepatol. 2014;20(4):406-10.
14. Sgroi MD, Narayan RR, Lane JS, Demirjian A, Kabutey NK, Fujitani RM, Imagawa DK. Vascular Reconstruction plays an Important Role in the Treatment of Pancreatic Adenocarcinoma. J Vasc Surg. 2015;61(2):475-80.
15. Roumanis PS, Aubin GK, Choi JI, Bhargava P, Demirjian AN, Thayer DA, Lall C. Atypical magnetic resonance imaging findings in hepatocellular carcinoma. Curr Probl Diagn Radiol. 2015;44(3):237-245.
16. Rinehart J, Lilot M, Lee C, Joosten A, Huynh T, Canales C, Imagawa D, Demirjian A, Cannesson M. Closed-loop assisted versus manual goal-directed fluid therapy during high-risk abdominal surgery: a case-control study with propensity matching. Crit Care. 2015;19(1):94.
17. Khalsa B, Imagawa DK, Chen JI, Demirjian AN, Yim DB, Findeiss LK. Evolution in the treatment of delayed postpancreatectomy hemorrhage: Surgery to Interventional Radiology. Pancreas. 2015;44(6):953-8.
18. Cannesson M, Ramsingh D, Rinehart J, Demirjian A, Vu T, Vakharia S, Imagawa D, Yu Z, Greenfield S, Kain Z. Perioperative goal directed therapy and postoperative outcomes in patients undergoing high-risk abdominal surgery: a historical-prospective, comparative effectiveness study. Crit Care. 2015;19(1):261.
Professional Societies
American Hepato-Pancreato-Biliary Association
American College of Surgeons, Fellow
Society for Surgery of the Alimentary Tract
Other Experience
Intern in Surgery
Beth Israel Deaconess Medical Center 2002—2003
Beth Israel Deaconess Medical Center 2002—2003
Resident in Surgery
Beth Israel Deaconess Medical Center 2003—2004
Beth Israel Deaconess Medical Center 2003—2004
Research Fellow in Gastrointestinal Surgery
Beth Israel Deaconess Medical Center 2004—2006
Beth Israel Deaconess Medical Center 2004—2006
Resident in Surgery
Beth Israel Deaconess Medical Center 2006—2008
Beth Israel Deaconess Medical Center 2006—2008
Chief Resident in Surgery
Beth Israel Deaconess Medical Center 2008—2009
Beth Israel Deaconess Medical Center 2008—2009
Fellow in Surgical Oncology
Johns Hopkins Hospital 2009—2011
Johns Hopkins Hospital 2009—2011
Link to this profile
https://faculty.uci.edu/profile/?facultyId=5975
https://faculty.uci.edu/profile/?facultyId=5975
Last updated
01/21/2016
01/21/2016